影响低近视的Ortho-K治疗因素和管理方法
Yuzhuo Fan1, Xuewei Li, Sitong Chen
1Department of Ophthalmology (Y.F., X.L., S.C., Y.L., M.Z., K.W.), Peking University People's Hospital, Beijing, China; Institute of Medical Technology (Y.F., X.L., S.C., Y.L., M.Z., K.W.), Peking University Health Science Center, Beijing, China; Beijing Key Laboratory of Ocular Disease and Optometry Science (Y.F., X.L., S.C., Y.L., M.Z., K.W.), Peking University People's Hospital, Beijing, China; and College of Optometry (Y.F., X.L., S.C., Y.L., M.Z., K.W.), Peking University Health Science Center, Beijing, China.
Eye & contact lens
|July 18, 2025
概括
治疗低近视的奥托克雷特 (Ortho-K) 治疗在女性,年轻患者,角膜平坦的人以及两个近视父母的孩子中效果较差. 将Ortho-K与氨酸和白肉饮食相结合可能会改善结果.
科学领域:
- 眼科医生 眼科 眼科
- 视光学测量 视光学测量 视光学测量
- 儿科眼科护理 儿科眼科护理
背景情况:
- 低近视管理对于防止进展至关重要.
- 正视治疗 (Ortho-K) 是一种常见的近视控制方法.
- 识别影响Ortho-K疗效的因素对于个性化治疗至关重要.
研究的目的:
- 为了确定影响低近视的Ortho-K治疗结果的人口统计,生物识别和行为因素.
- 为了探索低近视的管理策略,接受了Ortho-K.
主要方法:
- 在380名接受Ortho-K治疗的人群中进行了为期12个月的回顾性研究.
- 使用了分层和多项逻辑回归分析.
- 确定了与治疗结果相关的生物识别特征和行为指标.
主要成果:
- 在低近视患者中,单独的Orthokerate (Ortho-K) 显示了快速轴向生长的可能性是Ortho-K与0.01%的氨酸相比的2.23倍.
- 女性性别,年龄较小,角膜曲率较平 (K平均值),以及有两个近视父母与更糟糕的Ortho-K结果有关.
- 富含白肉的饮食表现出一种保护作用,与较慢的轴长度增长相关.
结论:
- 低近视患者具有危险因素 (年龄较小,女性,平面K平均值,两个近视父母) 需要更密切的监测.
- 组合疗法 (Ortho-K含有0.01%的类素) 可能比Ortho-K单一疗法更有效.
- 饮食修改 (白肉) 和行为管理是近视控制的重要辅助.
相关概念视频
01:27Open Angle Glaucoma: Treatment
577
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
577
01:16Focusing of Light in the Eye
3.2K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
3.2K
01:28Angle Closure Glaucoma: Treatment
691
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
691
01:15Diabetes: Management and Pharmacotherapy
399
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
399
01:25Glaucoma: Overview
771
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
771
01:26Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36